128 related articles for article (PubMed ID: 17683511)
1. Overexpression of CYP2A6 in human colorectal tumors.
Matsuda Y; Saoo K; Yamakawa K; Yokohira M; Suzuki S; Kuno T; Kamataki T; Imaida K
Cancer Sci; 2007 Oct; 98(10):1582-5. PubMed ID: 17683511
[TBL] [Abstract][Full Text] [Related]
2. CYP2A6 overexpression in human lung cancers correlates with a high malignant status.
Matsuda Y; Yamakawa K; Saoo K; Hosokawa K; Yokohira M; Kuno T; Iwai J; Shirai T; Obika K; Kamataki T; Imaida K
Oncol Rep; 2007 Jul; 18(1):53-7. PubMed ID: 17549345
[TBL] [Abstract][Full Text] [Related]
3. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
Alqurashi N; Gopalan V; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
[TBL] [Abstract][Full Text] [Related]
4. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
[TBL] [Abstract][Full Text] [Related]
5. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
[TBL] [Abstract][Full Text] [Related]
6. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
7. Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation.
Ropponen KM; Kellokoski JK; Pirinen RT; Moisio KI; Eskelinen MJ; Alhava EM; Kosma VM
J Clin Pathol; 2001 Jul; 54(7):533-8. PubMed ID: 11429425
[TBL] [Abstract][Full Text] [Related]
8. Role of human cytochrome P450 (CYP) in the metabolic activation of nitrosamine derivatives: application of genetically engineered Salmonella expressing human CYP.
Kamataki T; Fujita K; Nakayama K; Yamazaki Y; Miyamoto M; Ariyoshi N
Drug Metab Rev; 2002 Aug; 34(3):667-76. PubMed ID: 12214673
[TBL] [Abstract][Full Text] [Related]
9. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors.
Kusaba T; Nakayama T; Yamazumi K; Yakata Y; Yoshizaki A; Nagayasu T; Sekine I
J Clin Pathol; 2005 Aug; 58(8):833-8. PubMed ID: 16049285
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.
Toyoda A; Kawana H; Azuhata K; Yu J; Omata A; Kishi H; Higashi M; Harigaya K
Int J Oncol; 2009 Jan; 34(1):53-60. PubMed ID: 19082477
[TBL] [Abstract][Full Text] [Related]
11. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
[TBL] [Abstract][Full Text] [Related]
12. DPEP1, expressed in the early stages of colon carcinogenesis, affects cancer cell invasiveness.
Toiyama Y; Inoue Y; Yasuda H; Saigusa S; Yokoe T; Okugawa Y; Tanaka K; Miki C; Kusunoki M
J Gastroenterol; 2011 Feb; 46(2):153-63. PubMed ID: 20824289
[TBL] [Abstract][Full Text] [Related]
13. Expression of the apoptosis inhibitor livin in colorectal adenoma-carcinoma sequence: correlations with pathology and outcome.
Wang Y; Li Y; Zhou B; Zhang WY; Guan JT; Wang R; Yang L; Xia QJ; Zhou ZG; Sun XF
Tumour Biol; 2014 Dec; 35(12):11791-8. PubMed ID: 25339450
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of upregulated DR-nm23 expression on invasion and metastasis in colorectal cancer.
Qu L; Liang L; Su J; Yang Z
Eur J Cancer Prev; 2013 Nov; 22(6):512-22. PubMed ID: 23765094
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of GRP78 and GRP94 is involved in colorectal carcinogenesis.
Takahashi H; Wang JP; Zheng HC; Masuda S; Takano Y
Histol Histopathol; 2011 Jun; 26(6):663-71. PubMed ID: 21472681
[TBL] [Abstract][Full Text] [Related]
16. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
[TBL] [Abstract][Full Text] [Related]
17. The correlation between IGF-II and Bcl-2 expression in colorectal adenocarcinoma.
Zhang MS; Hu AH; Qiu H; Xiong HH; Chen Y
Med Oncol; 2012 Jun; 29(2):928-32. PubMed ID: 21380782
[TBL] [Abstract][Full Text] [Related]
18. The clinicopathological significance of REIC expression in colorectal carcinomas.
Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
[TBL] [Abstract][Full Text] [Related]
19. Expression of the ets-1 proto-oncogene in human colorectal carcinoma.
Nakayama T; Ito M; Ohtsuru A; Naito S; Sekine I
Mod Pathol; 2001 May; 14(5):415-22. PubMed ID: 11353051
[TBL] [Abstract][Full Text] [Related]
20. Measurement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells.
Crawford EL; Weaver DA; DeMuth JP; Jackson CM; Khuder SA; Frampton MW; Utell MJ; Thilly WG; Willey JC
Carcinogenesis; 1998 Oct; 19(10):1867-71. PubMed ID: 9806171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]